ARWR

NASDAQ

Arrowhead Pharmaceuticals, Inc. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$10.80B

PE Ratio

47.7701

EV to Ebitda

30.8767

Earnings Yield

2.09%

Revenue (TTM)

$1.09B

Net Income (TTM)

$233.6M

Revenue (Annual YoY Growth)

23258.15%

Revenue (Quarterly YoY Growth)

10461.32%

Profit Margin

21.41%

Return on Equity

50.20%

Debt to Equity Ratio

1.21

Dividend Yield

0.00%

All fundamentals

Core11 fields›

Market Cap$10.80B

Revenue TTM$1.09B

Shares Outstanding140.0M

Float117768187

Float Short9.81%

Days To Cover5.7087119858

Short Interest11971887.0

Insider Ownership5.44%

Volume452891

Relative Strength94.8

GARP3059

Growth Estimates14 fields›

Revenue Growth (Annual)23258.15%

Revenue Growth (Quarterly YoY)10461.32%

Operating Revenue Growth (Annual)0.566279

Operating Revenue Growth (Quarterly YoY)0.505186

3-Year Revenue Growth50.52%

5-Year Revenue Growth56.63%

EPS Growth (Annual)99.76%

EPS Growth (Quarterly YoY)115.80%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate0.00%

EBITDA Growth (Annual)120.99%

EBITDA Growth (Quarterly YoY)130.22%

CFO Growth (Annual)138.79%

CFO Growth (Quarterly YoY)108.91%

Operations28 fields›

Revenue TTM$1.09B

Gross Margin TTM97.70%

Gross Margin (Quarterly)97.58%

R&D % of Revenue TTM57.22%

R&D Expenses TTM$624.3M

Operating Margin TTM27.55%

Operating Margin (Quarterly)15.46%

Operating Expenses TTM$765.3M

Profit Margin TTM21.41%

Profit Margin (Quarterly)10.70%

Net Income TTM$233.6M

EPS TTM1.5382

EPS (Quarterly)0.219

EBIT Margin TTM27.55%

EBIT Margin (Quarterly)15.46%

EBITDA Margin TTM29.85%

EBITDA Margin (Quarterly)17.88%

EBITDA TTM$325.6M

CFO % of Revenue TTM21.65%

CFO % of Revenue (Quarterly)5.11%

CFO TTM$344.3M

Cash Margin31.41%

Capex % of Revenue TTM1.59%

Capital Expenditures$17.3M

FCF % of Revenue TTM18.91%

FCF % of Revenue (Quarterly)4.29%

FCF TTM$327.0M

Fundamental Score5

Efficiency6 fields›

ROE50.20%

ROA16.63%

ROIC19.23%

CROCI26.92%

Stock Comp % (Quarterly)7.34%

Stock Comp % TTM7.64%

Valuation18 fields›

P/E (TTM)47.7701

P/E Ex-Cash43.5147

P/S Forward23.8044

P/CFO29.3409

P/FCF30.893

EV/EBITDA (TTM)30.8767

EV/EBITDA Forward-26.3496

EV/Revenues (TTM)9.2165

EV/Revenues Forward23.2617

EV/CFO25.8109

EV/FCF (TTM)30.7486

Price To Book18.102

Price to Tangible Book8.7124

Earnings Yield2.09%

FCF Yield3.24%

Dividend Yield0.00%

Payout Ratio0.00%

Value Score2

Relative to Industry10 fields›

Relative Gross Margin (Quarterly)1.2502

Relative P/E3.2608

Relative P/S1.5095

Relative P/B4.056

Relative Earnings Yield0.3067

Relative Dividend Yield0

Relative ROE1.5047

Relative ROA0.9402

Relative ROIC0.7893

Relative Debt to Equity3.542

Liquidity15 fields›

Cash Per Share6.6715

Current Ratio3.3803

Cash & ST Assets$916.6M

Total Debt$680.2M

Goodwill & Intangibles$6.4M

Total Assets$1.60B

Total Liabilities$1.04B

Shareholders Equity$568.4M

Debt to Equity1.21

Debt to Assets42.87%

Interest Expense$90.2M

Times Interest Earned3.3315

CFO to Debt (TTM)0.4594

Debt to EBITDA (TTM)2.3014

Goodwill % of Assets0.40%

Yields5 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield2.09%

Buyback Yield-2.88%

Shareholder Yield-2.89%

Options Flow8 fields›

Call Volume1037

Put Volume490

Put/Call Ratio0.4725168756027001

Call $ Volume742014

Put $ Volume368422

Put/Call $ Ratio0.49651623823809254

Call OI25623

Put OI12269